Singapore Institute of Advanced Medicine (SGX:9G2) narrowed its loss before tax in the fiscal third quarter ended March 31 to SG$5.7 million from SG$6.2 million a year earlier, according to a Thursday bourse filing.
Loss per share from continuing operations stood at SG$0.0046 compared with SG$0.0059 in the year-ago period.
Revenue declined 4% year over year to SG$3.8 million from SG$3.9 million.